Analyst Ratings for Pacific Biosciences of California (pacb)
pacb Rating Summary
pacb Price Target Summary
- Highest: $8.00 (JPMorgan)
- Lowest: $4.50 (Credit Agricole)
- Average: $6.25
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.25 (+158.3%)
Avg. $ Target:
$6.25 (+158.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/30/2012 | Morgan Stanley | Downgrade | Underweight (Equalweight) |
N/A (N/A) |
2.00 | 2.42 | 21% | Details |
| 7/27/2012 | Piper Jaffray | Downgrade | Underweight (Neutral) |
N/A (N/A) |
1.77 | 2.42 | 36.72% | Details |
| 9/26/2011 | Credit Agricole | Downgrade | Underperform (N/A) |
4.50 (N/A) |
4.04 | 2.42 | -40.1% | Details |
| 9/21/2011 | JPMorgan | Downgrade | Underweight (N/A) |
8.00 (N/A) |
5.56 | 2.42 | -56.47% | Details |
| 6/21/2011 | Maxim Group | New Coverage | Hold (N/A) |
N/A (N/A) |
11.57 | 2.42 | -79.08% | Details |
| 4/19/2011 | William Blair | New Coverage | Market Perform (N/A) |
N/A (N/A) |
12.95 | 2.42 | -81.31% | Details |
| 3/17/2011 | Oppenheimer | New Coverage | Perform (N/A) |
N/A (N/A) |
13.48 | 2.42 | -82.05% | Details |
| 1/24/2011 | Gleacher & Co. | New Coverage | Neutral (N/A) |
N/A (N/A) |
14.34 | 2.42 | -83.12% | Details |
| 12/6/2010 | Deutsche Bank | New Coverage | Buy (N/A) |
N/A (N/A) |
12.97 | 2.42 | -81.34% | Details |
